| __timestamp | Blueprint Medicines Corporation | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 22223073 |
| Thursday, January 1, 2015 | 48588000 | 6966842 |
| Friday, January 1, 2016 | 81131000 | 9000499 |
| Sunday, January 1, 2017 | 144687000 | 13741186 |
| Monday, January 1, 2018 | 243621000 | 19040000 |
| Tuesday, January 1, 2019 | 331450000 | 23559000 |
| Wednesday, January 1, 2020 | 326860000 | 31931000 |
| Friday, January 1, 2021 | 601033000 | 44981000 |
| Saturday, January 1, 2022 | 477419000 | 54234000 |
| Sunday, January 1, 2023 | 427720000 | 63806000 |
| Monday, January 1, 2024 | 341433000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and Viking Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Blueprint Medicines increased its R&D spending by over 1,200%, peaking in 2021 with a staggering 600% increase from its 2014 levels. This aggressive investment underscores their strategic focus on pioneering new treatments. In contrast, Viking Therapeutics, while also increasing its R&D budget, maintained a more conservative growth, with a 187% rise over the same period. This divergence highlights the varied approaches within the biotech sector, where some companies prioritize rapid innovation, while others adopt a more measured pace. As the industry evolves, these strategic choices will shape the future of medical breakthroughs.
Eli Lilly and Company vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
R&D Insights: How Johnson & Johnson and Viking Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Pfizer Inc. and Blueprint Medicines Corporation
R&D Spending Showdown: GSK plc vs Viking Therapeutics, Inc.
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Viking Therapeutics, Inc.
argenx SE or Viking Therapeutics, Inc.: Who Invests More in Innovation?
Incyte Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Intra-Cellular Therapies, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Blueprint Medicines Corporation or CymaBay Therapeutics, Inc.: Who Invests More in Innovation?
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and Viking Therapeutics, Inc.
Research and Development Investment: Blueprint Medicines Corporation vs Viridian Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.